Comments
Search
Ticker Summary (LLY)
| 35.60+0.15 (+0.42%) | |
|---|---|
| Open | 35.26 |
| High | 35.82 |
| Low | 35.05 |
| Volume | 7,662,729 |
| Market Cap | 39.3B |
| 52 Week High | 38.00 |
| 52 Week Low | 32.02 |
| P/E | 8.81 |
| F P/E | 7.91 |
| EPS | 4.04 |
| Dividend | 1.96 |
| Yield | 5.53% |
| 1 Year Target | 35.91 |
LLY 35.60 +0.42%
Eli Lilly and Company India launced an injection treatment named Byetta aimed to improve blood sugar control for patients with type 2 diabeties in India. Byetta is not a replacement for insulin; instead, Byetta is designed to help the body make more of its own insulin. India is now the fourth major market to have Byetta approved, following successful launches in the US, UK, and Germany.
+0
| Circulate
Submit comment
Please sign in or register to leave a comment.
Top 10 in LLY
1.
